{"id":50956,"date":"2022-11-16T17:02:24","date_gmt":"2022-11-16T16:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/"},"modified":"2022-11-16T17:02:24","modified_gmt":"2022-11-16T16:02:24","slug":"eu-addiction-policy-from-prohibition-to-harm-reduction","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/","title":{"rendered":"EU Addiction Policy: From Prohibition to Harm Reduction"},"content":{"rendered":"
\n

BRUSSELS & PRAGUE–(BUSINESS WIRE)–National addiction policy makers and experts met in Brussels yesterday to discuss the Czech presidency of the Council of the EU and the best way to tackle various addictions, including alcohol, tobacco, gambling and digital technologies, at EU level. The consensus is that the priority should be a holistic, compassionate and realistic approach to help those in need.<\/b>\n<\/p>\n

<\/a><\/p>\n

\n“A world without drugs, tobacco, alcohol is not realistic and perhaps not healthy for people’s mental health. Extreme regulations have little effect on addictive behaviour,” said national drug coordinator Jind\u0159ich Vobo\u0159il<\/b>, adding: “What we can effectively do is to minimise the impact. Addiction policy should give adults access to less risky addictive products and let people make their own choices.”\n<\/p>\n

\nThe roundtable also discussed the perspective on tackling addiction and the role that EU agencies such as the EMCDDA should play in this regard.\n<\/p>\n

\n“The European Parliament has sent a clear signal in its report on the Europe\u2019s Beating Cancer Plan by stressing the importance of realistic, evidence-based policies. The European Commission should listen to the experts and take a rational and science-based approach,” said MEP Radka Maxov\u00e1<\/b>.\n<\/p>\n

\nViktor Mrav\u010d\u00edk, Head of IRAP’s Science Department, presented examples from the Czech Republic where a comprehensive harm reduction approach to alcohol and tobacco dependence has led to success. In the discussion that followed, Ale\u0161 Rod, member of National Advisory Committee on the Economy and Head of the Centre for Economic and Market Analysis<\/b>, presented his recent study<\/a> on best practices in managing tobacco dependence policies in several Member States, including the Czech Republic and Sweden.\n<\/p>\n

\n“If we conclude that a drug-free world is not possible, we should consider the implications of regulation. I also call on the upcoming Swedish presidency of the Council of the EU to address these issues as a matter of priority and ultimately help Europeans to tackle their addictions. After all, Sweden has done a lot in this area,” added Swedish psychologist and expert on addictions Karl Fagerstrom<\/b>.\n<\/p>\n

\nENDS\n<\/p>\n

\nNote to the editor:\n<\/p>\n

\nThe Institute for Rational Addiction Policies<\/i><\/a> (IRAP) is a multidisciplinary association of independent and distinguished experts who are dedicated to research and education in the field of addiction from all perspectives.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nIRAP
\n
secretariat@addiction-policy.eu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BRUSSELS & PRAGUE–(BUSINESS WIRE)–National addiction policy makers and experts met in Brussels yesterday to discuss the Czech presidency of the Council of the EU and the best way to tackle various addictions, including alcohol, tobacco, gambling and digital technologies, at EU level. The consensus is that the priority should be a holistic, compassionate and realistic … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50956","6":"format-standard","7":"category-industry"},"yoast_head":"\nEU Addiction Policy: From Prohibition to Harm Reduction - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU Addiction Policy: From Prohibition to Harm Reduction - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BRUSSELS & PRAGUE–(BUSINESS WIRE)–National addiction policy makers and experts met in Brussels yesterday to discuss the Czech presidency of the Council of the EU and the best way to tackle various addictions, including alcohol, tobacco, gambling and digital technologies, at EU level. The consensus is that the priority should be a holistic, compassionate and realistic ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T16:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221116005622\/en\/1639869\/21\/Screenshot_2022-11-16_at_15.31.02.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"EU Addiction Policy: From Prohibition to Harm Reduction\",\"datePublished\":\"2022-11-16T16:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/\"},\"wordCount\":388,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005622\\\/en\\\/1639869\\\/21\\\/Screenshot_2022-11-16_at_15.31.02.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/\",\"name\":\"EU Addiction Policy: From Prohibition to Harm Reduction - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005622\\\/en\\\/1639869\\\/21\\\/Screenshot_2022-11-16_at_15.31.02.jpg\",\"datePublished\":\"2022-11-16T16:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005622\\\/en\\\/1639869\\\/21\\\/Screenshot_2022-11-16_at_15.31.02.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005622\\\/en\\\/1639869\\\/21\\\/Screenshot_2022-11-16_at_15.31.02.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/eu-addiction-policy-from-prohibition-to-harm-reduction\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU Addiction Policy: From Prohibition to Harm Reduction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU Addiction Policy: From Prohibition to Harm Reduction - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/","og_locale":"en_US","og_type":"article","og_title":"EU Addiction Policy: From Prohibition to Harm Reduction - Pharma Trend","og_description":"BRUSSELS & PRAGUE–(BUSINESS WIRE)–National addiction policy makers and experts met in Brussels yesterday to discuss the Czech presidency of the Council of the EU and the best way to tackle various addictions, including alcohol, tobacco, gambling and digital technologies, at EU level. The consensus is that the priority should be a holistic, compassionate and realistic ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T16:02:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221116005622\/en\/1639869\/21\/Screenshot_2022-11-16_at_15.31.02.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"EU Addiction Policy: From Prohibition to Harm Reduction","datePublished":"2022-11-16T16:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/"},"wordCount":388,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005622\/en\/1639869\/21\/Screenshot_2022-11-16_at_15.31.02.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/","url":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/","name":"EU Addiction Policy: From Prohibition to Harm Reduction - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005622\/en\/1639869\/21\/Screenshot_2022-11-16_at_15.31.02.jpg","datePublished":"2022-11-16T16:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221116005622\/en\/1639869\/21\/Screenshot_2022-11-16_at_15.31.02.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221116005622\/en\/1639869\/21\/Screenshot_2022-11-16_at_15.31.02.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/eu-addiction-policy-from-prohibition-to-harm-reduction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"EU Addiction Policy: From Prohibition to Harm Reduction"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50956"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50956\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}